Medical Research News and Research

RSS

Phase III study shows tapentadol ER relieves chronic pain associated with DPN

New research has been published indicating that patients suffering from a painful complication of diabetes may experience a significant improvement in their pain as measured by a pain intensity scale when using an investigational pain medication.

29 Jan 2011

Genetic study helps investigators solve medical mysteries

The mystery began in 1976. Adolfo Pampena was diagnosed with a rare form of cancer that caused a strange combination of symptoms and was associated with the occurrence of multiple tumours in his stomach and colon. His medical team was stumped and was unable to answer the most important questions for him and his family: the cause of his disease and the risk for future generations.

29 Jan 2011

BioTime announces acquisition of CTI assets

BioTime, today announced that it has acquired substantially all the assets of Cell Targeting, a Cleveland, Ohio-based biotechnology company conducting research in regenerative medicine.

29 Jan 2011

Cedars-Sinai's director receives lifetime achievement award for medical research, mentorship

The Western Society of Clinical Investigation has honored David L. Rimoin, M.D., Ph.D., director of the Cedars-Sinai Medical Genetics Institute, with its 2011 Mayo Soley Award for lifetime achievement in medical research and mentorship.

29 Jan 2011

NIH awards CCTSI $2.2 million grant to advance personalized medicine

A federal grant totaling $2.2 million shows how the University of Colorado School of Medicine and Anschutz Medical Campus are using technology to advance the cutting-edge field of personalized medicine -- tailoring treatments to the individual based on their genetic make-up.

28 Jan 2011

EHIL creates new software tool to protect health research participants' privacy

In recognition of Data Privacy Day 2011, the Electronic Health Information Laboratory is making a new software tool freely available to the medical research community to protect personal privacy while helping to advance medical research.

28 Jan 2011

H3 Biomedicine introduces cancer research and development operations in Cambridge

H3 Biomedicine today announced that it has launched research and development operations in Cambridge, Massachusetts. H3 Biomedicine will undertake a comprehensive approach to breakthrough oncology treatments based on two primary principles: 1) the genetics of patients' cancers can reveal drug targets tailored to their cancers and 2) the advances in modern chemistry enable the discovery of new classes of safe and effective drugs against these targets.

27 Jan 2011

Gestational diabetes raises risk of diabetes and weight problems in babies: Study

The latest Australian research suggests that women who have diabetes during pregnancy – also known as gestational diabetes, are more likely to have children who will battle diabetes and weight problems through their lives. The research is published in the journal Diabetologia, now online.

27 Jan 2011

CHUV university hospital to implement OpenTrust Crypt'n'Share for secure exchange of sensitive information

OpenTrust, the Next-Gen IT security software publisher, today announced that the CHUV university hospital in Lausanne has chosen to use OpenTrust Crypt'n'Share to securely exchange sensitive information throughout the establishment.

27 Jan 2011

Fixed Phage to develop products based on Strathclyde's technology for tackling infections

A new company has been launched to commercialise an award-winning technology, developed at the University of Strathclyde in Glasgow, for tackling bacterial infection and contamination, including superbugs such as MRSA.

25 Jan 2011

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

Researchers from the Royal College of Surgeons in Ireland (RCSI) and Beaumont Hospital have made a breakthrough in understanding the mechanisms behind the most severe form of hereditary emphysema and how protein treatments can improve the condition. The findings of this study may also lead to new treatments for patients with smoker's emphysema.

24 Jan 2011

Cell binding mechanism can lead to new treatments for skin diseases, lethal heart defects

A University of Manchester scientist has revealed the mechanism that binds skin cells tightly together, which he believes will lead to new treatments for painful and debilitating skin diseases and also lethal heart defects.

From The University of Manchester 21 Jan 2011

PROSPECT trial results shed new light on plaque types that cause unexpected heart attacks

Results from the PROSPECT clinical trial shed new light on the types of vulnerable plaque that are most likely to cause sudden, unexpected adverse cardiac events, and on the ability to identify them through imaging techniques before they occur.

21 Jan 2011

Malaria parasite caught in action on film for the first time

Australian researchers have managed to take pictures of microscopic malaria parasite as it invades a human red blood cell. This will provide a deeper understanding of the parasite’s behaviour and may help fight it. Up to 10% of the world’s population contract malaria every year and a million people, mostly pregnant women and children, die as a result of the parasite transmitted by infected mosquitoes.

19 Jan 2011

Point Of Care Solutions introduces AMP for physicians to manage medical practices

Point of Care Solutions introduces its Agile Medical Platform, the latest integrated practice management and ambulatory Electronic Health Record system available in the United States to manage physician medical practices with a ubiquitous interface.

19 Jan 2011

Alternative interventions do just as well as cognitive interventions for reducing 'senior moments'

Trying to stave off senior moments with memory drills and similar brain-boosting activities? A new evidence review suggests that these specific training regimes are not any better than simple conversations at improving memory in older adults.

19 Jan 2011

Meganucleases used to prevent HSV-1 infection

Cellectis, announced today that scientists from Cellectis therapeutics, the French National Center For Medical Research (CNRS) and Institut de la Vision (Paris) have used its proprietary meganucleases to successfully prevent infection of cultured cells by a Herpes Simplex virus (HSV-1).

19 Jan 2011

New patented technique offers unprecedented view of DNA damage

New technology providing the first view of DNA damage throughout the entire human genome developed by Cardiff University scientists could offer a valuable new insight into the development and treatment of conditions like cancer.

19 Jan 2011

More studies needed to evaluate harm or benefit of mechanical CPR

Pushing on the chest to simulate the heart's rhythmic pumping action is an essential part of cardiopulmonary resuscitation after cardiac arrest. In recent decades, manufacturers have developed several mechanical devices that claim to perform CPR more effectively than human efforts alone.

19 Jan 2011

Study may help develop novel ways to combat lipotoxic cardiomyopathy, related heart disease

A team led by Rolf Bodmer, Ph.D. at Sanford-Burnham Medical Research Institute recently unraveled an alternative pathway to lipotoxic cardiomyopathy in fruit flies - a genetic mechanism that occurs independently of a diet high in fat.

19 Jan 2011

Medical Research News and Research

Phase III study shows tapentadol ER relieves chronic pain associated with DPN

Genetic study helps investigators solve medical mysteries

BioTime announces acquisition of CTI assets

Cedars-Sinai's director receives lifetime achievement award for medical research, mentorship

NIH awards CCTSI $2.2 million grant to advance personalized medicine

EHIL creates new software tool to protect health research participants' privacy

H3 Biomedicine introduces cancer research and development operations in Cambridge

Gestational diabetes raises risk of diabetes and weight problems in babies: Study

CHUV university hospital to implement OpenTrust Crypt'n'Share for secure exchange of sensitive information

Fixed Phage to develop products based on Strathclyde's technology for tackling infections

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

Cell binding mechanism can lead to new treatments for skin diseases, lethal heart defects

PROSPECT trial results shed new light on plaque types that cause unexpected heart attacks

Malaria parasite caught in action on film for the first time

Point Of Care Solutions introduces AMP for physicians to manage medical practices

Alternative interventions do just as well as cognitive interventions for reducing 'senior moments'

Meganucleases used to prevent HSV-1 infection

New patented technique offers unprecedented view of DNA damage

More studies needed to evaluate harm or benefit of mechanical CPR

Study may help develop novel ways to combat lipotoxic cardiomyopathy, related heart disease

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News